March 8, 2024
Cambridge, Mass. - Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures [...]
March 8, 2024
BOHEMIA, NY -- Scientific Industries, Inc. ("SI") (OTCQB:SCND) announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc. ("SBI"), effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. John A. Moore, Chairman of SI, said "We are [...]
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
March 7, 2024
BASEL, Switzerland -- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization, and [...]
Oxford Nanopore launches PromethION 2 Integrated into open early access
March 7, 2024
The PromethION 2 Integrated sets a new standard for convenience and efficiency in DNA, RNA, and cDNA sequencing. With its onboard computing capabilities, the self-contained device is bringing high-quality sequencing to a wider range of research and academic labs. Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, [...]
Nabsys Opens a Distribution Channel for the OhmX™ Platform in Canada
March 7, 2024
PROVIDENCE, R.I. -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform. OhmX is Nabsys' first commercially available product and was released in October 2023. DMark will be responsible for distributing both the Nabsys OhmX™ Analyzer and consumables into both public and private research core [...]
March 7, 2024
FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company's manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions. The Wuxi facility offers the advantage of fostering unique vendor [...]
Tom O’Lenic joins RedShiftBio as Chief Executive Officer
March 7, 2024
BOXBOROUGH MA. --RedShiftBioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for the measurement of protein characterization and protein concentration used in biotherapeutic drug development and manufacturing, proudly announces the appointment of Tom O’Lenic as its new Chief Executive Officer (CEO). With over two decades of experience in commercial leadership and management roles, O’Lenic brings [...]
March 6, 2024
WALTHAM, Mass. -- NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to quantify proteins and nucleic acids in a single run, enabling the simultaneous detection and characterization of adeno-associated virus (AAV) [...]
SOPHiA GENETICS Announces New Customer in Costa Rica
March 6, 2024
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Universidad de Costa Rica El Centro de Investigación en Cirugía y Cáncer (CICICA) is now live on the SOPHiA DDM™ [...]
March 5, 2024
Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers. BOULDER, CO InDevR Inc., a global leader in vaccine testing and multiplexed assay development for vaccine manufacturers, is excited to announce the launch of OmniFlu HA, a validated, off-the-shelf kit for seasonal influenza vaccine [...]
